Association between common carotid artery diameter and target organ damage in essential hypertension. 2018

Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
Department of Hypertension, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Vascular Biology, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine.

To investigate the relationship between common carotid artery diameter (CCA-D) and target organ damage (TOD) in essential hypertension. A total of 200 essential hypertensive patients were enrolled (mean age 62.5 ± 9.5, men 59.0%) and were classified into two groups by the height-adjusted mean median of CCA-D: patients with CCA-D/height less than 3.905 mm/m (n = 100, 50%) and patients with CCA-D/height more than 3.905 mm/m (n = 100, 50%). Patients with CCA-D/height more than 3.905 mm/m have higher left ventricular mass index (LVMI) (P < 0.001) and higher prevalence of left ventricular hypertrophy (LVH) (P < 0.001), higher mean common carotid intima-media thickness (P = 0.008) and higher prevalence of carotid artery sclerosis (P = 0.03), higher pulse wave velocity (PWV) (P < 0.001) and higher prevalence of increased arterial stiffness (P = 0.01), higher urinary albumin/creatinine ratio (P = 0.001) and higher prevalence of microalbuminuria (P = 0.02) and greater number of TODs (P < 0.001) compared with the patients with CCA-D/height less than 3.905 mm/m. CCA-D was significantly correlated with LVMI, PWV and logarithmically transformed urinary albumin/creatinine ratio (r = 0.299, P < 0.001; r = 0.212, P = 0.007; r = 0.224, P = 0.005, respectively) after adjusting for cardiovascular risk factors. Multivariable stepwise linear regression analysis showed that number of TODs as well as individual TOD, including LVMI, PWV and logarithmically transformed urinary albumin/creatinine ratio, were independently correlated to height-adjusted mean CCA-D (all P < 0.05). Height-adjusted mean CCA-D was an independent risk factor for individual TOD, including LVMI, PWV and urinary albumin/creatinine ratio, as well as overall number of TODs in essential hypertension.

UI MeSH Term Description Entries
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075222 Essential Hypertension Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500 Primary Hypertension,Hypertension, Essential,Hypertension, Primary,Hypertensions, Primary,Primary Hypertensions
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
August 2000, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
June 1998, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
July 2019, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
July 2008, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
December 2012, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
February 2003, Current hypertension reports,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
March 2002, American journal of hypertension,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
December 2013, Hypertension (Dallas, Tex. : 1979),
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
January 2011, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Yan Yang, and Yan Wang, and Jianzhong Xu, and Pingjin Gao
November 1996, American journal of hypertension,
Copied contents to your clipboard!